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proximately 17% of medical schemes popu-
lation [2].
The GDP of 8.6% is also not comparable to 
other countries of similar developmental sta-
ges and it does not translate to improved he-
alth outcomes within both public and private 
health care sectors. Furthermore, the Council 
for Medical Schemes (CMS) observed that 
high expenditure within private health care 
is largely influenced by hospital admissions, 
whereby, between 2008 and 2010, private 
hospital expenditure – which includes ward 
fees, theatre fees, consumables, medicines 
and per diem arrangements – consumed 
between 40.5% and 40.9% of the total be-
nefits paid by medical schemes from the risk 
pool, whilst total hospital benefits paid from 
the medical savings accounts ranged between 
BACKGROUND
A well functioning private health care in-
surance system does not only promote fair 
distribution of the burden of paying health 
services or protect households against the 
risks of catastrophic health care expenditure; 
it also reduces barriers to health service use. 
In South Africa, private health expenditure 
is mainly financed through medical schemes 
contributions and out-of-pocket payments. 
According to National Treasury, the total an-
nual health expenditure by both public and 
private health care sectors constitutes appro-
ximately 8.6% of the GDP (gross domestic 
product) and this is a split of between 4.1% 
for private sector and 4.2 % in the public 
sector [1]. Blecher et al. also argued that the 
4.1% spend on private health care covers ap-
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ABSTRACT
BACKGROUND: In South Africa, private hospitals absorb a high proportion of the total health expenditure on private he-
alth care. Between 2008-2010 private hospital expenditure which includes ward fees, theatre fees, consumables, medicines 
and per diem arrangements consumed between 40.5% and 40.9% of the total benefits paid by medical schemes from the risk 
pool, whilst in-hospital managed care fees ranged between 1.8% and 2.8% for the equivalent years.
OBJECTIVE: The aim of this paper is to highlight key factors contributing to utilisation of hospital services within the me-
dical schemes population and to recommend “appropriate” and cost effective strategies on hospital utilisation management.
METHODS: A cross sectional survey informed by retrospective analysis of quantitative data was used. Researchers also 
triangulated quantitative data with systematic review of literature.
RESULTS: The results show that demographic indicators such as age profile, dependency ratio, pensioner ratio and preva-
lence of chronic conditions are not the only key factors influencing hospital admissions, but rather the effectiveness of each 
medical scheme in containing hospital admissions is also influenced by available technical capacity on utilisation review 
and audit as well as the managed care methodology including the philosophy underpinning benefit option design.
CONCLUSION: This study highlights the importance of “value based” managed care programs linked to benefit option 
design in health care utilisation management. The choice of one managed care program over the other often leads to trade-
offs whereby unintended consequences emanate. Medical schemes are therefore encouraged to continuously review their 
managed care programs to ensure value for money as well as better access and health outcomes.
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1.5% and 2.1%. In addition, in-hospital ma-
naged care arrangement fees ranged between 
1.8% and 2.8% for the equivalent years [3].
This observed increase on private health care 
costs, including hospital services, has lead 
to an increase in medical schemes contribu-
tion rates above Consumer Price Index (CPI) 
ranging between 9-13% whilst the CPI ran-
ged between 4% and 9% [4]. This implies 
that over the past years private health care in 
South Africa has become exorbitantly unaf-
fordable, and this trend has lead to a marginal 
increase in the total population covered by 
medical schemes. In light of this context, a 
study was undertaken to explore factors in-
fluencing utilisation of in hospital services 
and medicine expenditure within the private 
health care sector. This research project ex-
plore determinants of in-hospital admission, 
length of stay, re-admission rate, day case ra-
tes and expenditure on medicine.
AIM
The aim of this paper is to highlight key fac-
tors contributing to utilisation of hospital 
services and medicine expenditure within the 
medical schemes population and to recom-
mend “appropriate” and cost effective stra-
tegies on hospital and medicine utilisation 
management.
METHODS
Conceptual framework
In order to gain in-depth understanding of 
factors influencing utilisation of health care 
services, a socio-behavioural and the Four 
As models presented below informed de-
velopment of indicators, data specification 
tool and analysis of data [5,6]. These mo-
dels, amongst other things, highlight the link 
between health insurance benefit packages, 
health seeking behaviour, location of the fa-
cility, social networks and socio-cultural fac-
tors as important attributes influencing utili-
sation of health services.
According to Andersen et al. [5], the fol-
lowing factors are important when exploring 
utilisation of health care services:
 - Predisposing factors: age, gender, social 
capital, ethnicity, educational status, prior 
experience on illness and health services.
 - Enabling factors: availability of servi-
ces, affordability, health insurance benefit 
packages and social network support.
 - Need factors: perception on severity, 
days lost due to illness.
 - Health services system factors: policy, 
resources and organisation of the health 
system.
 - Consumer satisfaction: physical, econo-
mical and political.
 - Personal health practice: diet, exerci-
se and home care (including home tre-
atment).
Hausmann-Muela et al. [6] emphasise the im-
portance of the importance of:
 - geographical distribution of health facili-
ties;
 - transport, roads and the associated costs;
 - direct, in-direct costs associated with ac-
cessing health care services;
 - socio-cultural factors.
Scope
The scope of this project was to collect quan-
titative data to inform key medicine and ho-
spital admission indicators at a medical sche-
me’s level over a period of 2008/2009.
Study design
This study undertook a descriptive cross 
sectional survey informed by retrospective 
review of quantitative data as well as qualita-
tive analysis of medical scheme rules, benefit 
option reports and actuarial reports. Resear-
chers also triangulated quantitative data with 
systematic review of literature which resulted 
in compilation and piloting of 40 health care 
utilisation measures within the private health 
care market across different facility types, 
medical schemes and administrators. The-
se utilisation measures included in-hospital 
care, out-of-hospital care, specialist care, use 
of diagnostic technology and expenditure 
on medicine. The piloting exercise resulted 
in scaling down on the scope of the project 
resulting in data collection of only 23 health 
care utilisation measures. Medical specia-
lists and out-of-hospital care measures were 
excluded from data collection due to lack of 
access to specialists and medical schemes be-
neficiaries for in-depth interviews.
Sampling frame
A non-random convenient sampling techni-
que was used to select 6 large schemes repre-
senting 55% of lives within the medical sche-
mes population and 13% of benefit options 
offered by the medical schemes.
Criterion validity of the 
selected indicators
The following parameters were used to in-
form the criteria for selecting hospital utili-
sation indicators:
 - Simplicity when calculating a combina-
tion of indicators to also ensure that par-
ticipants in the study are not blinded by 
obscure statistical or mathematical theo-
ry [7].
85Farmeconomia. Health economics and therapeutic pathways 2012; 13(2) © SEEd All rights reserved
N. G. Khumalo, M. Willie, E. Thsehla
 - Reviewing of the definition of each in-
dicator including technical criteria/guide-
line on the analysis and interpretation of 
observations.
 - Producing composed scales to create a 
single variable from a set of questions and 
also to make graphics or tables that show 
relationships.
 - Descriptive analysis of data by produ-
cing descriptive statistics, such as means, 
standard-deviations, histograms, etc.
Responder validation
The observations outlined in this paper were 
validated against participating medical sche-
mes and administrators as well as compared 
to HQA reports for the corresponding years. 
The responder validation process facilitated 
on ongoing communication with the schemes 
and administrators on various issues and 
observations. Researchers were also able to 
identify missing data; in addition, schemes 
had an opportunity to review submitted data. 
Preliminary findings were also presented to 
all research participants in order to afford 
each medical scheme an opportunity to enga-
ge with the results as well as to contextualise 
observed trends.
Figure 1. Proportion of sampled beneficiaries by age bands
 - Relevance to the utilisation context 
within the South African private health 
care market.
 - Scientific soundness of the measure in 
terms of its validity, reliability, appropria-
teness and the explicitness of the eviden-
ce base.
 - Feasibility and availability of data.
The above criteria informed the inclusion and 
exclusion criteria used for the systematic re-
view of literature and relevant papers were 
identified using the following approach:
 - Database searches and reference snow 
bowling guided by the study’s inclusion 
and exclusion criteria.
 - Consultation with Council for Medical 
Schemes (CMS) Clinical Committee 
members as well as medical schemes, 
administrators, managed health care or-
ganisations, private hospital groups and 
independent health actuaries.
 - The definition of each indicator was re-
viewed to ensure appropriateness (based 
on the criteria discussed above).
 - Utilisation indicators used in other 
countries were evaluated to ensure com-
parability and applicability to the South 
African private health care market.
 - Possible data sources were identified for 
each indicator (Table I).
 - All indicators were piloted to improve re-
liability, validity and responsiveness.
Data analysis
The following are key steps undertaken when 
analysing quantitative data:
 - Data cleaning to make sure that the col-
lected data was clean and reliable.
 - Reviewing completeness and accuracy 
of data to eliminate errors before analysis.
Data type Source of data 
Beneficiary 
utilisation data 
ICD10 codes (and relevant diagnosis data) from medical 
schemes and administrators  
Hospital 
utilisation data 
Medical schemes and administrators (ICD10 codes, 
NHRPL codes and NAPPI codes )
Secondary data CMS annual reports and 2008/2009 Health Quality 
Assessment (HQA) reports, actuarial reports, medical 
schemes rules and benefit option reports
Table I. Sources of data
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RESULTS
Demographic indicators
Membership profile – which includes avera-
ge age, pension’s ratio, gender differentiation 
and dependency ratio – influences the fre-
quency and the claiming profile within each 
scheme. Average age of the medical scheme 
population also influence hospital expenditu-
re per beneficiary. For example, older people 
go to hospital more often than younger peo-
ple, and once they are admitted, on average 
they cost more than younger patients during 
their stay in hospital. Figure 1 portrays a pro-
portion of sampled beneficiaries by age ban-
ds from 2008-2010. It was observed that in 
2010 membership of the sampled schemes 
increased by close to 50.9%. Also outlined 
in the graph the increase in the proportion of 
beneficiaries is present across all age bands.
Figure 2 provides an outline of the average 
age of beneficiaries within each selected me-
dical schemes. This indicator can influence 
hospital admission, length of stay, probability 
of re-admission, use of diagnostic technology 
as well as medicine expenditure. Noted in the 
observations is that scheme 3 and scheme 4 
appear to have a relatively older profile when 
compared to other schemes. It would therefo-
re be expected that such scheme would expe-
rience a relatively high proportion of hospital 
admission cases, which was not the case.
Figure 3 illustrates the distribution of pensio-
ner ratio for each scheme. It is important to 
note that scheme 4 appears to have a relati-
vely high pensioner ratio when compared to 
Figure 2. Average age 2008/2009
all other schemes. In 2009 the proportion of 
pensioners within the selected schemes was 
slightly higher compared to 2008.
Prevalence of chronic conditions
South Africa is experiencing a quadruple 
burden of disease; this trend includes AIDS 
pandemic, high rates of injury, infectious di-
seases as well as non-communicable disea-
ses (NCDs). According to Medical Research 
Figure 3. Pensioner ratio for 2008/2009 Figure 4. Prevalence of chronic conditions in schemes (per 1000 beneficiaries). Source: 2009 Annual Statutory Returns data CMS
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burden of disease; this trend includes AIDS 
pandemic, high rates of injury, infectious di-
seases as well as non-communicable disea-
ses (NCDs). According to Medical Research 
Figure 3. Pensioner ratio for 2008/2009 Figure 4. Prevalence of chronic conditions in schemes (per 1000 beneficiaries). Source: 2009 Annual Statutory Returns data CMS
Council (MRC), NCDs affect a large number 
of the working-age population, thereby im-
pacting on the workforce and productivity of 
the country [8]. The major NCDs in South 
Africa include cardiovascular diseases, dia-
betes, cancers, chronic respiratory diseases, 
and mental illness. The national surveillance 
on the burden of disease suggests that unhe-
althy lifestyle is one of the key contributing 
factors to the prevalence of chronic illnesses 
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in South Africa (MRC, 2011). Figure 4 
shows prevalence of chronic conditions 
within the selected schemes. The chronic di-
sease permeates several aspects of health 
service utilization and can be implicated in 
many diagnoses; therefore, all services for 
all relevant ICD-10 diagnostic codes were 
included. This provided a fair presentation of 
chronic disease health service use. For the 
purpose of this study, the prevalence of chro-
nic disease was defined as every beneficiary 
who has any of the selected chronic condi-
tions in a specific financial year (January-
December) was counted, and for beneficiari-
es with multiple conditions, each condition 
was counted separately. Table II provides an 
outline of the top six chronic conditions ex-
perienced by members of the sampled sche-
mes.
It appeared that schemes are generally expe-
riencing more non-communicable diseases 
with hypertension being high for both open 
and restricted schemes, whilst Figure 5 and 
Table II show that HIV/AIDS prevalence was 
relatively high for one restricted scheme 
compared to most schemes.
Chronic conditions 
per 1,000 beneficiaries
Open schemes Restricted schemes
Hypertension 106,227 67,503
Hyperlipidemia 51,349 23,974
Asthma 29,456 17,026
Diabetes mellitus type 2 25,440 23,215
HIV 9,506 24,948
Hypothyroidism 17,618 9,783
Table II. Chronic conditions per 1000 beneficiaries
Figure 5. HIV/Aids prevalence per 1000 beneficiaries (2009). Source: 2009 Annual Statutory Returns data CMS
Managed care and benefit 
option design
Managing health care risk amongst other 
things includes efforts in controlling medi-
cal benefit costs. Such efforts require an em-
phasis in cost sharing and cost effectiveness 
analysis of various managed care models 
whilst conforming to the government’s sta-
tutory requirements (provision of prescribed 
minimum benefit). Benefit option design the-
refore plays an important role in influencing 
health care utilization through a variety of 
ways including:
 - The schemes choice of managed care mo-
del (i.e., pre-authorization system, patient 
channelling, discharge planning, use of 
GP networks, case management, designa-
ted service provider network (DSP), etc.).
 - Benefit limits, co-payments and/or cap-
ping the number of visits.
 - Use of formularies.
 - Differences in reimbursement models for 
various components of the benefit packa-
ge (i.e., payments at scheme’s tariff rate, 
capitation agreements, etc.).
 - Use of clinical protocols to manage utili-
zation cost effectively.
This section provides a summary of key dif-
ferences outlined by research participants as 
differentiating benefit option design within 
open and restricted schemes. Observations 
made in this study show that the benefit 
structure for open and restricted schemes is 
slightly different, reasons cited as influencing 
the difference include:
 - Differences in the philosophy underpin-
ning benefit option configuration.
 - Impact of volatility of the health insuran-
ce market.
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 - Uncertainty in determining premium rates 
(i.e. projections based on assumptions).
 - Uncertainty and risks due to changes in 
the regulatory environment.
Table III provides a summary of key differen-
ces observed within the study relating to in-
hospital admission, MRI scans and medicine 
utilization. These observations were based on 
the review of all selected medical scheme ru-
les; actuarial reports as well as feedback from 
responder validation meetings.
The utilization trend observed within this stu-
dy as well as in Table III highlights key diffe-
rences as well as the impact of each managed 
care model/protocol and benefit option rules 
Benefit design 
Open 
schemes
Restricted 
schemes
Impact on utilization 
Facility based case managers Yes * - Better coordination of in-hospital patient care, discharge planning 
and better health outcomes (i.e. low re-admission rate)
Benefit limits /co-payments 
on MRI scans (excluding PMB 
conditions)
Yes - Schemes with unlimited access to MRI scans were observed to be 
experiencing high utilisation when compared to schemes with some 
benefit limits. For example, literature suggests that close to 80% of 
back pain, knee pain or suspected cartilage tear do not require MRI 
scan interventions therefore schemes should first determine clinical 
necessity before granting access
Payments of MRI scans from 
the medical savings account 
/above threshold benefit 
(excluding PMB conditions)
Yes ** - Figure 11 illustrates the impact of paying MRI scans from the MSA/
day to day benefits. Schemes have to manage trade-offs and 
addressing overuse, some elements of “supply induced demand” 
without denying their members access to required care 
Use of brand medicine 
vs. generic medicine 
Yes - All the restricted schemes appear to have been able to channel their 
patients towards use of generic medicine opposed to 3 of 4 open 
schemes (Figure 14) 
Table III. Benefit option design and impact on utilisation.Note: MRI scan utilization included in-hospital and out-of hospital care as 
well as Prescribed Minimum Benefits (PMB) and non PMB conditions
* Only one out of 3 open schemes sated that they were using facility based case managers within some of their networks
** Out of the four open schemes who participated in this project 3 schemes pay MRI scans from the medical savings account/ATB within certain 
benefit options
in facilitating and/or monitoring utilization. 
The choice of one managed care model over 
the other often leads to tradeoffs whereby 
unintended consequences emanate. Further-
more, the effectiveness of each of the above 
program/s depends largely on each schemes 
and/or its internal administration’s technical 
capacity, financial resources as well as tech-
nical rigor in utilization review and manage-
ment.
In-hospital admission
As indicated earlier, utilisation of in-hospital 
services is often influenced by demographic 
factors, burden of disease including preva-
Figure 6. Number of admissions stratified by hospital admission facility
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lence of HIV pandemic and improvements 
in medical technology as well as managed 
care interventions. Between 2008 and 2010 
private hospital expenditure – which includes 
ward fees, theatre fees, consumables, medici-
nes and per diem arrangements – consumed 
between 40.5% and 40.9% of the total bene-
fits paid by medical schemes from the risk 
pool, whilst total hospital benefits paid from 
the medical savings accounts ranged between 
1.5% and 2.1%. In addition, in-hospital ma-
naged care arrangement fees ranged between 
1.8% and 2.8% for the equivalent years [9]. 
This section provides an outline of in-hospi-
tal utilisation trends with a specific focus on 
total admissions stratified by departmental 
type, average length of stay, re-admission 
rate, as well as the total number of day cases.
Total admissions: hospital 
units/departments
Critical care is widely recognized as being 
both expensive and increasing within South 
Africa and internationally. This section re-
views patient flow between general ward, 
ICU and high care within a hospital. Figure 6 
provides an outline of the total number of ad-
mitted cases within each hospital department. 
As can be observed, 87% of the admitted ca-
ses were in the general ward compared to 
13% and 1% of High Care and ICU. Only 2 
schemes experienced more cases attracting 
theatre admissions compared to all other 
schemes. Also noted in Figure 6 is that sche-
me 2 and 3 reported significantly lower num-
ber on theatre admissions.
Average length of stay
The average length of stay (ALOS) measures 
how much time patients spend in hospitals. 
This is a proxy measure for quality of care 
as well as efficiency within hospitals. In most 
cases a persistently high ALOS might mean 
that patients are being kept in hospital for too 
long therefore indicating inefficiency. Inter-
pretation of this indicator should take into 
account case mix as well as exclusion of long 
term care, day cases and all ambulatory visits 
from the calculation. For the purpose of the 
study ALOS was defined as discharge date – 
admission date, where admission and dischar-
ge on the same day were thus viewed as LOS 
= 0. Results presented in this section excluded 
all of the above cases but due to unavailability 
of disaggregated data researchers were unable 
to do a case mix adjustment.
Figure 7 shows that restricted schemes have a 
relatively high ALOS compared to open sche-
mes with a range between 2.6 and 3.7. When 
one compares the industry average as publi-
shed by CMS for 2008/2009/2010 the ALOS 
range was between 3.7 and 6.2, which is re-
latively higher than the observed trend. Also, 
when comparing ALOS with Figure 5 it was 
observed that one key contributing factor to 
the high ALOS for restricted schemes can be 
attributed to high prevalence of HIV/AIDS. 
Figure 7 also illustrates that some open sche-
mes are able to contain ALOS to remain 
within same levels over a period of time (i.e., 
scheme 1, scheme 2 and scheme 3) whilst 
others have experienced variable distribu-
tion.
Re-admission
Re-admission to a hospital shortly after di-
scharge may be viewed as an adverse outcome 
of care. This indicator is useful for monitoring 
quality and it can also be used to identify pro-
Figure 7. Average length of stay
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viders whose quality of care may be inferior, 
so that appropriate corrective measures may be 
undertaken [10]. For the purpose of the study, 
re-admission rate is defined as re-admissions 
within 28 days, where count of admissions for 
same beneficiary where admission_date(2) – 
discharge_date(1) < 29 days.
Effectiveness of discharge planning may redu-
ce the length of hospital stay, and in some ca-
ses may reduce re-admissions also, case ma-
nagers within managed care programmes 
often play a critical role in this regard. A tho-
rough analysis and interpretation of this indi-
cator should include adjusting data to cater for 
disease severity, complexity of cases, hospital 
type (public and/or private), planned sequence 
of care, age and gender differentiation if pa-
tient level data are available. Even though re-
sults presented below were not adjusted for all 
the above factors, a correlation of average age 
and pensioner ratio was undertaken. Figures 7 
and 8 show the distribution of re-admission 
rate across all selected schemes, with a range 
between 11% and 36% compared to average 
age and pensioner ratio. It appeared that re-
stricted schemes experienced high re-admis-
sion rates compared to open schemes; this 
observation is relatively more than the obser-
vation made within open schemes whilst the 
average age and pensioner ratio for both sche-
mes is relatively low when compared to other 
schemes. This trend also correlates well with 
the ALOS presented above.
Same day admissions
This indicator is an estimate of the poten-
tial cost savings that could be achieved if 
Figure 8. Re-admission rate, average age and pensioner ratio
Figure 9. Same day cases per 1000 admissions
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relevant specialists achieved a high rate of 
day-case as opposed to in-hospital admitted 
cases. For the purpose of this study same 
day admissions was defined as a count ad-
missions with LOS = 0. For this indicator to 
give accurate picture, procedures which can 
be carried out safely as a day case need to 
be comprehensively defined. Figure 9 shows 
an outline of day cases per 1000 admissions. 
As can be observed, the distribution of day 
cases range between a minimum of 248 cases 
per 1000 admissions and a maximum of 364 
cases with an average of 300 cases. Scheme 
3 and 4 appeared to have the highest number 
of day cases when compared to other sche-
mes whilst their average age for both years 
is high.
Medicine expenditure
According to a study undertaken by Ander-
sen et al., evidence on medicine expenditu-
re shows that up to 90% of the population 
in developing countries purchase medicines 
through out-of-pocket payments, making me-
dicines one of the largest family expenditure 
after food [5]. Cameron also contends that 
over time medicines have become unafforda-
ble for a large section of the population and 
can be a major burden on patients and a bar-
rier towards access to health care [11].
South Africa shares the context as outlined 
above. The implementation of Single Exit 
Price (SEP) in 2004 lead to a 19-21% cost 
savings on medicine expenditure [12]. From 
2007 the gains through SEP regulation started 
to wear away, the Council for Medical Sche-
mes noticed an increase in medicine expen-
diture whereby medicine become the third 
highest cost driver in private health care [9]. 
This study undertook an analysis on medici-
ne expenditure within the context of explo-
ring the effectiveness of medical schemes in 
medicine utilisation review and management.
Figure 10 shows an outline of chronic, acute 
and oncology expenditure across all selected 
schemes. As can be observed, average expen-
diture on acute medicine is higher than chro-
nic medicine and oncology. This is an undesi-
red observation since chronic medicine can 
be expensive and when chronic patients are 
enrolled in chronic disease program schemes 
can prevent unnecessary complications lea-
ding to in-hospital admission.
As above mentioned, formularies and proto-
cols are part of managed cared interventions 
used to promote cost-effective use of medi-
cines. Usually medicine included within the 
schemes formulary is covered in full without 
out-of pocket payment and for most schemes, 
medicines on the formulary list will include 
generics.
Member utilisation of the schemes formulary 
depends on the following factors:
 - member’s knowledge of their entitle-
ments;
 - benefit option purchased (some options 
cover medicine costs in full);
 - co-payments;
 - scheme rules;
 - if the condition being treated is a Prescri-
bed Minimum Benefit condition or not.
Figure 11 shows that most schemes appear to 
be spending more on formulary medicine 
compared to non-formulary. Ideally, where 
appropriate, all schemes should channelling 
Figure 10. Chronic, Acute and Oncology expenditure
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their members towards use of generic medi-
cine as per the Medicines and Related Sub-
stances Control Act which mandates: «Phar-
macists to offer patients a generic substitute 
for any medicine prescribed, unless the pre-
scribing doctor explicitly states that the me-
dicine should not be substituted».
Furthermore, since the implementation of the 
Medicines and Related Substances Control 
Act in 1997 [13], there has been an increased 
use of generic medicines between 2003 until 
recently by some medical schemes. This stu-
dy noted with concern that in spite of this re-
gulatory intervention, only 2 schemes were 
able channel their members towards use of 
generics for both 2008 and 2009 (Figure 12). 
Especially since most brand medicine tend to 
Figure 11. Formulary and Non formulary expenditure
attract co-payments (depending on the bene-
fit option). As such, the Council for Medical 
Schemes has observed an increased inciden-
ce of co-payments highlighting the discre-
pancy between amounts charged by provi-
ders and what medical schemes are prepared 
to pay. This trend has been evidenced throu-
gh the increase in the use of medical savings 
accounts which, in most cases, leads to mem-
bers exhausting their benefits before the end 
of the financial year.
DISCUSSION
Data presented in this paper provide an over-
view on how schemes are managing utilisa-
tion for selected private health care services. 
Figure 12. Generic and Brand Medicine expenditure
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PROJECT CHALLENGES
The following are key challenges encounte-
red within the research project:
 - Use of aggregated data as opposed to di-
saggregated data.
 - Not all schemes were able to categorize 
total hospital admissions by Diagnosis-
related Groups (DRGs).
 - Medical schemes and administrators also 
have different perspectives on the defini-
tion and computation of health care utili-
sation measures.
 - Use of different Information Technology 
Systems to capture and interpret benefi-
ciary information.
 - There are also limited surveys on private 
health care utilisation measures as well as 
industry norms and standards.
 - Some stakeholders only captured primary 
ICD10 codes as opposed to both primary 
and secondary ICD10 codes.
 - There is limited access to patient’s clini-
cal notes from the providers.
 - Project did not include option level 
analysis in order to explore impact of 
changes in demographic profile on utili-
sation.
 - There aer differences in risk adjustment 
methodology by different stakeholders.
Most of these challenges were addressed in 
the piloting exercises which lead to the de-
velopment and finalisation of the data speci-
fication as well as the responder validation 
exercise which facilitated consultation with 
the medical schemes and administrators.
CONCLUSION
Since benefit option design is one of the key 
factors influencing the outlined utilisation 
trends, medical schemes should cautiously 
manage trade-offs between cost savings in-
terventions and barriers to appropriate care. 
Such trade-offs should always seek encoura-
ge equity, health outcomes and quality. Me-
dical schemes can evaluate such programs 
continuously to ensure that they are highly 
responsive to each members needs.
In order to manage escalation of costs where 
possible medical schemes should continual-
ly channel their patients towards appropriate 
level of care in order to avoid out-of-pocket 
payments by members.
Medical schemes should also educate their 
members on their benefit entitlements and 
responsibilities along with associated benefit 
limits.
Data presented in this paper provide a valua-
ble foundation for further research within pri-
vate health care specifically, within the area of 
benefit option design addressing issues around 
This study also highlights particular areas 
within which medical schemes can impro-
ve and contain hospital admission. Whilst 
acknowledged that hospital admissions in-
cluding length of stay and re-admission ra-
tes are complex indicators which requiring 
data to be adjusted for clinical factors such 
as type of diagnosis, disease severity, com-
plexity of the case/condition being treated, 
hospital type and size (private/public hospi-
tals), this paper shows the importance of ef-
fective managed care programs including ef-
fective use of case managers. Dieterich et al. 
concur by also suggesting that «one strategy 
for dealing with avoidable re-admissions is 
for case managers to interview all re-admit-
ted patients to gain an understanding on why 
re-admission occurred as well as undertake 
a review of patient’s clinical record to esta-
blish causality» [14].
Whilst Dieterich’s recommendation might 
be ideal, it is acknowledged that not all 
medical schemes will have resources to 
employ on-site facility managers. It is the-
refore recommended that medical schemes 
should identify low resource and easy to im-
plement best practise guidelines for preven-
tion of avoidable hospital admissions such 
as: review of characteristics and processes 
along the care continuum, profiling of pro-
viders, discharge planning, care coordina-
tion, patient education on self-administra-
tion of medication and effects of medicine 
mismanagement, home health care after 
discharge, use of step-down facilities where 
applicable.
The most effective way of controlling health 
care costs also includes the scope of benefits 
provided, including associated costs but also 
to manage the appropriateness of utilization 
and influence the price paid to providers. All 
these objectives underlie benefit option de-
sign of managed care plans/programs. Bene-
fit limits are one such intervention and have 
always been used within the South African 
medical schemes industry; however such li-
mits often have a potential of exposing me-
dical schemes members to substantial out-
of-pocket costs thereby infringing on equity 
consideration whilst in extreme cases, bene-
fit limits may give members the impression 
of entitlement which is expected to be used 
regardless of the health care need. Although 
in most cases members who are in need of 
cover are likely going to be the ones exhau-
sting their benefits therefore effective ma-
naged care programs including continuous 
assessment of benefit limits as well as an 
analysis of the impact of such limits to mem-
bers and clinical necessity should always be 
reviewed.
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ding an analysis of other utilisation indicators 
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Schemes in a form of a working paper. This 
manuscript has not been published in any 
scientific journal.
cost escalation; value based managed care 
interventions, financial protect of members 
and unpacking medicine expenditure trends 
linking observations to the risk profile of the 
scheme along with prevalence of disease.
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